MARKET WIRE NEWS
  1. Home
  2. Stock
  3. ACAD
  4. News
Download Market Wire News App
ACAD
Quote
Short
News
Articles
Message Board

ACADIA Pharmaceuticals Inc. (NASDAQ : ACAD ) News

News Releases

ACAD News Releases
ACAD : NASDAQ
Motley Fool
An Acadia Pharmaceuticals Insider Sold Nearly Half Their Shares in the Company. What Does That Mean for Investors?
ACAD : NASDAQ
Business Wire
Acadia Pharmaceuticals Appoints Carl Segerstrom as Chief People Officer
ACAD : NASDAQ
SeekingAlpha
About That 'Robust' Earnings Growth
ACAD : NASDAQ
SeekingAlpha
Taysha: 'Buy' On Interim Analysis Of TSHA-102 First Half 2027 And Broad Label Potential
ACAD : NASDAQ
SeekingAlpha
Acadia Pharmaceuticals: Steady Commercial Progress, Remlifanserin Data In Focus
ACAD : NASDAQ
KlickAnalytics
ACAD Price Target Alert: $37.00. Issued by Deutsche Bank
ACAD : NASDAQ
Motley Fool
Why Acadia Pharmaceuticals Stock Is Soaring Today
ACAD : NASDAQ
SeekingAlpha
Acadia rises as EU backs Rett syndrome therapy
ACAD : NASDAQ
Business Wire
DAYBU® (trofinetide) Recommended for Approval in the European Union by CHMP
ACAD : NASDAQ
SeekingAlpha
Acadia Pharmaceuticals: The Song Remains The Same
Next 10

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.